Genscript Biotech Corporation
Genscript Biotech Corporation (GNNSF) Revenue
Annual & quarterly revenue history · segment & region breakdown
GNNSF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsGenscript Biotech Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
BiotechnologyCompare GNNSF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Genscript Biotech Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Genscript Biotech Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Genscript Biotech Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
GNNSF revenue · 4 questionsGNNSF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Genscript Biotech Corporation SEC filings · GAAP · Genscript Biotech Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026